evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies).
With a track record of more than 120,000 successful antibody production runs for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland).
You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
Company Details
- Employees
- 31
- Founded
- -
- Address
- Brunaustrasse 185, Zürich-Fahrweid,switzerland 8951,switzerland
- ev****@****ria.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- evitria.com
- Keywords
- Antibody production, Bispecific antibody production, Antibody engineering, Preclinical research.
- HQ
- Zürich-Fahrweid, Switzerland
Evitria Ag Questions
Evitria Ag's website is evitria.com
Evitria Ag's LinkedIn profile is https://ch.linkedin.com/company/evitria-ag
Evitria Ag has
31 employees.
View email and phone details for 31
employees at Evitria Ag.
Evitria Ag's industry is
Biotechnology Research
Evitria Ag's top competitors are
Bright Peak Therapeutics,
Atlas Antibodies,
Molecular Partners,
Lonza,
Athebio Ag,
Neurimmune Ag,
Dinaqor,
Immunos Therapeutics Ag,
Bioatrium Ag,
Celonic Group.
Evitria Ag's support email address is evitria@evitria.com
Evitria Ag's categories are Biotechnology Research
Evitria Ag's founding year is 2010
